The news for the product is good, but its still carrot dangling before the AGM and the final dilution.
I am sure many news starved holders in the hole with there investment will be hoping this is the miracle.
"the TAVR market is expected to be $US12 billion by 2025."
This is the sort of spin that really highlights what WP is all about.
What portion of this spend is for the actual devices that are implanted?
Once you remove doctors fees, surgical staff , hospital costs and patient care costs.
What is the value of the market for the devices.
Surely they can tell us this.
We have seen it all before with the valuation of the patch market.
How has that worked out?
- Forums
- ASX - By Stock
- AVR
- Ann: Promising Interim Results from TAVR Animal Study
Ann: Promising Interim Results from TAVR Animal Study, page-8
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M |
Open | High | Low | Value | Volume |
$10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 300 | $9.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.91 | 475 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300 | 9.800 |
1 | 200 | 9.600 |
1 | 2 | 9.540 |
1 | 330 | 9.510 |
2 | 1185 | 9.500 |
Price($) | Vol. | No. |
---|---|---|
9.910 | 475 | 2 |
9.990 | 99 | 1 |
10.000 | 250 | 1 |
10.500 | 10005 | 2 |
11.000 | 5000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online